AMH and ovarian carcinoma: It is necessary to perform further studies to determine the tissue expression of AMH and type II receptor for AMH in ovarian cancer tissue and the potential usefulness of monoclonal antibodies against AMH and its receptor in the diagnosis and treatment of women with ovarian cancer.